Skip Navigation LinksHome > We Invest > Indiana Future Fund > Indiana Future Fund I Investments

Indiana Future Fund I Investments

 

Endocyte

A West Lafayette, Ind.-based company that is pioneering a new generation of receptor-targeted therapeutics or “smart” drugs that reduce side effects by targeting drugs to receptors present on diseased cells. Focuses are on the treatment of cancer and autoimmune diseases.

QuadraSpec Inc.

Developing a BioCD and other products which enable a user to directly detect up to 1,000 unique antigens, biomarkers or other molecular species on a single array.

 

CoLucid Pharmaceuticals

A development stage biopharmaceutical company focused on discovering and developing treatments for neurological dysfunctions.

BioStorage Technologies

A premier provider of advanced biomaterials storage, inventory management and worldwide cold chain logistics.

SonarMed

Developing a line of breathing tubes using sonar technology

CS-Keys

Developing cancer specific “biomarkers” using advanced protein technologies

Home  |  Contact Us  |  Newsroom  |  Sitemap

Follow Us:  

Copyright BioCrossroads 2010